A Study of Stellate Ganglion Block for Prevention of Atrial Fibrillation
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.
Also called NCT05357690
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase
- Phase 2/3
- Enrolled
- 200 participants
- Sponsor
- Registry
-
NCT05357690
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT05357690. Randomized; quadruple masking; primary purpose prevention. Start 2023-04-19 (actual); primary completion 2026-06-08 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of Stellate Ganglion Block for Prevention of Atrial Fibrillation
- Condition
- Atrial Fibrillation
- Intervention (Procedure)
- Stellate ganglion block
- Intervention (Drug)
- Bupivacaine
- Intervention (Drug)
- Placebo
- Lead sponsor
- Mayo Clinic
Record details
- Record id
cardio:ct-nct05357690- Content hash
75e1a86f04a413fc39f958bb919a99590e30340cca06494d16f5b4cbdf9547ad